FdaApplication
ANDA 212088
Identifiers
- fda_app_no: ANDA212088
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2020-06-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE | TABLET, DELAYED RELEASE;ORAL |
1 product